The CD59 Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-111124 |
| Réf. fabricant | 18293313 |
| À utiliser avec (application) | Western Blot |
| Lignée cellulaire | The lysate was created in HEK293T cells, using plasmid ID RC218343 and based on accession number NM_611. The protein contains a C-terminal DDK tag. |
| Quantité | 0.1 mg |
| Tampon de stockage | RIPA buffer |
| Pureté | Protein |
| Spécificité du test | Homo sapiens CD59 molecule, complement regulatory protein (CD59), transcript variant 2, mRNA. |
| Contenu et stockage | -80°C. Avoid freeze-thaw cycles. |
| Synonyme | 16.3A5, 1F5, 1F5 antigen, 20 kDa homologous restriction factor, CD59 antigen, CD59 antigen, complement regulatory protein, CD59 glycoprotein, CD59 molecule, complement regulatory protein, EJ16, EJ30, EJ30, EL32 and G344), EL32, FLJ38134, FLJ92039, G344, HRF20, HRF-20, human leukocyte antigen MIC11, Ly-6-like protein, lymphocytic antigen CD59/MEM43, MACIF, MAC-inhibitory protein, MAC-IP, MEM43, MEM43 antigen, membrane attack complex (MAC) inhibition factor, Membrane attack complex inhibition factor, Membrane inhibitor of reactive lysis, MGC2354, MIC11MSK21, MIN1, MIN2, MIN3, MIRL, p18-20, protectin, surface anitgen recognized by monoclonal 16.3A5, T cell-activating protein |
| Protein State | Native |
